Meridian Bioscience, Inc. (NASDAQ:VIVO)

CAPS Rating: 5 out of 5

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.


Player Avatar TempoAllegro (30.45) Submitted: 9/12/2012 9:57:29 AM : Outperform Start Price: $16.76 VIVO Score: -41.70

VIVO makes a range of diagnostic tests for foodborne, parasitic, viral, and other diseases that you can do at home. The kits are now available in North America, Europe, Africa, and the Middle East.

With increasing threats to the food supply and environmental concerns such as lack of proper water for both humans and livestock, these tests will be both helpful and in greater demand in coming years.

Add to that its great balance sheet - currently with zero debt and current ratio of over 5, plus high insider ownership, generous dividend, and 5-year projected growth in the mid-teens, and we have an excellent addition to anyone's health-oriented portfolio.

Featured Broker Partners